Results from the study conducted by Kirtane in 2008 showed that rates of stent thrombosis and all-cause mortality were similar among DM patients treated with DES and Bare Metal Stents (BMS) irrespective of insulin-treated or non-insulin treated status. The gene discussed is INS; the disease is diabetes mellitus.